DE282711C - - Google Patents

Info

Publication number
DE282711C
DE282711C DENDAT282711D DE282711DA DE282711C DE 282711 C DE282711 C DE 282711C DE NDAT282711 D DENDAT282711 D DE NDAT282711D DE 282711D A DE282711D A DE 282711DA DE 282711 C DE282711 C DE 282711C
Authority
DE
Germany
Prior art keywords
anthracene
solution
yellow
acid
aceanthrenequinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT282711D
Other languages
German (de)
English (en)
Publication of DE282711C publication Critical patent/DE282711C/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/62—Cyclic imides or amidines of peri-dicarboxylic acids of the anthracene, benzanthrene, or perylene series

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
DENDAT282711D Active DE282711C (en:Method)

Publications (1)

Publication Number Publication Date
DE282711C true DE282711C (en:Method)

Family

ID=538341

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT282711D Active DE282711C (en:Method)

Country Status (1)

Country Link
DE (1) DE282711C (en:Method)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Similar Documents

Publication Publication Date Title
DE282711C (en:Method)
DE484360C (de) Verfahren zur Darstellung von organischen Rhodanverbindungen
DE3022783C2 (en:Method)
DE923690C (de) Verfahren zur Herstellung metallhaltiger Phthalocyanine
DE906935C (de) Verfahren zur Herstellung von Isolierung von Zwischenprodukten der Phthalocyaninsynthese
DE360530C (de) Verfahren zur Einfuehrung von Arylaminogruppen in Aminoanthrachinone
DE269842C (en:Method)
DE238981C (en:Method)
DE259145C (en:Method)
DE535148C (de) Verfahren zur Darstellung von Oxazinverbindungen
DE287756C (en:Method)
DE280092C (en:Method)
DE250154C (en:Method)
DE97639C (en:Method)
DE556486C (de) Verfahren zur Darstellung von Schwefelsaeureestern der Leukoverbindungen Nitrogruppen enthaltender indigoider Kuepenfarbstoffe
DE426347C (de) Verfahren zur Herstellung von Aminobenzanthronderivaten
DE430631C (de) Verfahren zur Darstellung von Beizenfarbstoffen der Phenanthrenchinonreihe
DE290983C (en:Method)
DE128955C (en:Method)
DE2846432C2 (en:Method)
DE234917C (en:Method)
DE445390C (de) Verfahren zur Herstellung von Dinaphthyldicarbonsaeuren
AT256850B (de) Verfahren zur Herstellung von neuen 3H-Pyrimido-[5,4-c]-1,2,5-oxadiazinderivaten
DE496393C (de) Verfahren zur Darstellung von Anthrachinon und seinen Abkoemmlingen
DE810052C (de) Verfahren zur Herstellung von Leukoschwefelsaeureestern verkuepbarer Verbindungen der Anthrachinon- und Indigoreihe